Three scientists, including researchers from Vertex Pharmaceuticals and the University of Iowa, received the prestigious Lasker Award for their groundbreaking work that significantly improved cystic fibrosis treatment and extended patient lifespans.
Three scientists received the $250,000 Lasker-DeBakey Award for developing Trikafta, a groundbreaking therapy that significantly extends the lifespan of cystic fibrosis patients by targeting the disease's genetic root, leading to improved quality of life and survival rates.
Three scientists from Vertex Pharmaceuticals and the University of Iowa received the prestigious Lasker Award for their groundbreaking work that significantly improved treatment and extended the lives of cystic fibrosis patients.
A study analyzing data on Nobel Prize winners in Physiology or Medicine from 1950 to 2009 suggests that recipients of the prestigious award tend to reduce their research output after winning. The analysis compared the number of published papers, novelty of ideas, and citations with winners of the Lasker Award. While Nobel Prize winners scored higher before receiving the prize, their productivity declined afterward. The study raises questions about the impact of the Nobel Prize on research and suggests recognizing scientists earlier in their careers to encourage innovative work.